DOI: 10.4244/EIJV9I9A189

What embolises to the brain during transcatheter aortic valve implantation?

Nicolas M. Van Mieghem1*, MD; Marguerite E.I. Schipper2, MD; Peter P. de Jaegere1, MD, PhD

An 83-year-old female patient underwent a transcatheter aortic valve implantation (TAVI) for symptomatic severe aortic stenosis with a high operative risk (logistic EuroSCORE 45%). The procedure was performed using the Montage™ Dual Filter embolic protection device (EPD) (Claret Medical, Inc., Santa Rosa, CA, USA), inserted through a right radial artery and encompassing the deployment of a proximal filter basket in the brachiocephalic trunk and a distal filter basket in the left common carotid artery (Figure 1A and Figure 1B). The procedure evolved uneventfully with successful deployment of a 29 mm Medtronic CoreValve™ (Medtronic Inc., Minneapolis, MN, USA) (Figure 1C). The EPD was then retrieved and contained a mixture of red and white material (with sizes varying from 1.5 to 7.1 mm) (Figure 1D). Figure 1E illustrates microscopic (magnification 2x) overview of two different fragments after haematoxylin & eosin (H&E) staining with material resembling tissue (*) and thrombus (**). Further analysis (magnification 20x) of the tissue fragment (Figure 1F) shows spindle-shaped fibroblasts with small purple nuclei and vacuolated proteoglycan-rich cytoplasm (light blue) partly covered by remnants of endothelial lining. These features can stem from large elastic arteries but seem more compatible with aortic valve leaflet origin given the absence of atherosclerosis or other typical hallmarks of vessel structures and bearing in mind the aortic root instrumentation during TAVI. Figure 1G (magnification 20x) demonstrates fibrin material (dark pink) mixed with clusters of platelets (blue), white blood cells (purple) and erythrocytes (red) and represents typical thrombus formation. Further research is warranted to assess whether the use of embolic protection devices will reduce the incidence of TAVI-related cerebrovascular embolisation and procedural stroke.

Figure 1. Transcatheter aortic valve implantation under cerebral embolic protection with the Montage Dual Filter and analysis of captured debris.

Conflict of interest statement

The authors have no conflicts of interest to declare.

Volume 9 Number 9
Jan 20, 2014
Volume 9 Number 9
View full issue


Key metrics

Suggested by Cory

Research Correspondence

10.4244/EIJ-D-23-00743 Feb 19, 2024
Final report of the PROTEMBO C Trial: a prospective evaluation of a novel cerebral protection device during TAVI
Fezzi S et al

Clinical research

10.4244/EIJ-D-23-00465 Dec 18, 2023
First-in-human study of the CAPTIS embolic protection system during transcatheter aortic valve replacement
Danenberg H et al
Trending articles
152.9

Clinical research

10.4244/EIJ-D-20-01125 Oct 20, 2021
An upfront combined strategy for endovascular haemostasis in transfemoral transcatheter aortic valve implantation
Costa G et al
free
47.8

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
39.1

Clinical research

10.4244/EIJ-D-22-00558 Feb 6, 2023
Permanent pacemaker implantation and left bundle branch block with self-expanding valves – a SCOPE 2 subanalysis
Pellegrini C et al
free
38.95

State-of-the-Art

10.4244/EIJ-D-23-00912 Oct 7, 2024
Optical coherence tomography to guide percutaneous coronary intervention
Almajid F et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved